Salem Investment Counselors’s SPDR S&P Biotech ETF XBI Stock Holding History

Salem Investment Counselors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$346K	Sell	4,176 -425	-9%	-$35.2K	0.01%	315
2025 Q1	$373K	Hold	4,601	–	–	0.01%	285
2024 Q4	$414K	Hold	4,601	–	–	0.01%	281
2024 Q3	$455K	Sell	4,601 -250	-5%	-$24.7K	0.01%	281
2024 Q2	$450K	Hold	4,851	–	–	0.01%	274
2024 Q1	$460K	Hold	4,851	–	–	0.02%	271
2023 Q4	$433K	Sell	4,851 -6,000	-55%	-$536K	0.01%	269
2023 Q3	$792K	Sell	10,851 -300	-3%	-$21.9K	0.03%	194
2023 Q2	$928K	Hold	11,151	–	–	0.03%	182
2023 Q1	$850K	Hold	11,151	–	–	0.03%	190
2022 Q4	$926K	Sell	11,151 -225	-2%	-$18.7K	0.04%	189
2022 Q3	$902K	Sell	11,376 -697	-6%	-$55.3K	0.04%	180
2022 Q2	$897K	Sell	12,073 -489	-4%	-$36.3K	0.04%	188
2022 Q1	$1.13M	Sell	12,562 -1,456	-10%	-$131K	0.04%	180
2021 Q4	$1.57M	Sell	14,018 -487	-3%	-$54.5K	0.05%	155
2021 Q3	$1.82M	Hold	14,505	–	–	0.1%	143
2021 Q2	$1.96M	Sell	14,505 -500	-3%	-$67.7K	0.11%	138
2021 Q1	$2.04M	Buy	15,005 +697	+5%	+$94.5K	0.12%	126
2020 Q4	$2.01M	Buy	14,308 +2	+0%	+$282	0.13%	122
2020 Q3	$1.59M	Buy	14,306 +1,400	+11%	+$156K	0.12%	120
2020 Q2	$1.45M	Buy	12,906 +56	+0.4%	+$6.27K	0.12%	121
2020 Q1	$995K	Hold	12,850	–	–	0.1%	134
2019 Q4	$1.22M	Sell	12,850 -105	-0.8%	-$9.99K	0.1%	136
2019 Q3	$988K	Sell	12,955 -3,550	-22%	-$271K	0.09%	140
2019 Q2	$1.45M	Buy	+16,505	New	+$1.45M	0.13%	126
2017 Q2	–	Sell	-11,950	Closed	-$829K	–	787
2017 Q1	$829K	Sell	11,950 -1,200	-9%	-$83.2K	0.09%	148
2016 Q4	$778K	Sell	13,150 -4,500	-25%	-$266K	0.09%	143
2016 Q3	$11.7K	Buy	17,650 +175	+1%	+$116	0.15%	113
2016 Q2	$945K	Sell	17,475 -3,024	-15%	-$164K	0.11%	137
2016 Q1	$1.06M	Sell	20,499 -5,100	-20%	-$263K	0.13%	128
2015 Q4	$1.79M	Hold	25,599	–	–	0.23%	97
2015 Q3	$1.58M	Sell	25,599 -8,946	-26%	-$552K	0.21%	102
2015 Q2	$2.91M	Buy	34,545 +510	+1%	+$42.9K	0.35%	76
2015 Q1	$2.56M	Buy	+34,035	New	+$2.56M	0.31%	83